CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



SCHERING-PLOUGH CORPORATION  (SGP)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
 
 


SCHERING-PLOUGH CORPORATION Segments

 
Clarinex/Aerius
   2.31 % of total Revenue
Remicade
   13.51 % of total Revenue
Nasonex
   2.56 % of total Revenue
PEG-Intron
   3.78 % of total Revenue
Temodar
   3.96 % of total Revenue
Intron
   0.56 % of total Revenue
Rebetol
   1.42 % of total Revenue
Claritin Rx
   2.11 % of total Revenue
Integrilin
   0.11 % of total Revenue
Total Pharmaceuticals
   78.86 % of total Revenue
Consumer Health Care
   6.27 % of total Revenue
Animal Health Care
   14.87 % of total Revenue
 

Business Segments (Sep. 30, 2009)
Revenues
(in millions $)
III. Quarter
%
(of total Revenues)
(Sep. 30, 2009)
Income
(in millions $)
III. Quarter
%
(Profit Margin)
Clarinex/Aerius
104.00 2.31 % 0.00 -
Remicade
608.00 13.51 % 0.00 -
Nasonex
115.00 2.56 % 0.00 -
PEG-Intron
170.00 3.78 % 0.00 -
Temodar
178.00 3.96 % 0.00 -
Intron
25.00 0.56 % 0.00 -
Rebetol
64.00 1.42 % 0.00 -
Claritin Rx
95.00 2.11 % 0.00 -
Integrilin
5.00 0.11 % 0.00 -
Total Pharmaceuticals
3,548.00 78.86 % 705.00 19.87 %
Consumer Health Care
282.00 6.27 % 58.00 20.57 %
Animal Health Care
669.00 14.87 % 76.00 11.36 %
Total
4,499.00 100 % 839.00 18.65 %

• View Income Statement • View Competition by Segment • View Annual Report

Growth rates by Segment (Sep. 30, 2009)
Y/Y Revenue
%
III. Quarter
Q/Q Revenue
%
(Sep. 30, 2009)
Y/Y Income
%
III. Quarter
Q/Q Income
%
Clarinex/Aerius
-40.91 % -53.98 % - -
Remicade
7.8 % 7.61 % - -
Nasonex
-55.43 % -64.17 % - -
PEG-Intron
-27.66 % -20.93 % - -
Temodar
-34.8 % -30.47 % - -
Intron
-59.02 % -62.69 % - -
Rebetol
1.59 % -4.48 % - -
Claritin Rx
9.2 % -1.04 % - -
Integrilin
-94.05 % -93.15 % - -
Total Pharmaceuticals
0.25 % -1.14 % 7.96 % -13.28 %
Consumer Health Care
1.44 % -25.98 % -22.67 % -3.33 %
Animal Health Care
-11.86 % -1.18 % -65.77 % -35.04 %
Total
-1.68 % -3.18 % -11.68 % -15.25 %

• View Growth rates • View Competitors Segment Growth • View Market Share

To get more information on Schering-plough's Clarinex/Aerius, Remicade, Nasonex, PEG-Intron, Temodar, Intron, Rebetol, Claritin Rx, Integrilin, Total Pharmaceuticals, Consumer Health Care, Animal Health Care, Total segment. Select each division with the arrow.

  Schering-plough's

Business Segments Description



The Company has three reportable segments: Prescription Pharmaceuticals, Consumer Health Care and Animal Health.

The Prescription Pharmaceuticals segment discovers, develops, manufactures and markets human ethical pharmaceutical products.

The Company continues to market CLARINEX (desloratadine) 5 mg Tablets for the treatment of allergic rhinitis, which combines the indication of seasonal allergic rhinitis with the indication of perennial allergic rhinitis, as well as the treatment of chronic idiopathic urticaria, or hives of unknown cause.

The ability of the Company to capture and maintain market share for CLARINEX and OTC CLARITIN in the U.S. market will depend on a number of factors, including: additional entrants in the market for allergy treatments; clinical differentiation of CLARINEX from other allergy treatments and the perception of the extent of such differentiation in the marketplace; the pricing differentials among OTC CLARITIN, CLARINEX, other allergy treatments and generic OTC loratadine; the erosion rate of OTC CLARITIN and CLARINEX sales upon the entry of additional generic OTC loratadine products; and whether or not one or both of the other branded second-generation antihistamines are switched from prescription to OTC status. CLARINEX is experiencing intense competition in the prescription U.S. allergy market.

Prescription Pharmaceuticals, which is organized into categories as follows:

Primary Care including

Allergy/ Respiratory

CLARINEX, NASONEX, FORADIL AEROLIZER

Antibiotics

AVELOX, CIPRO

Dermatologicals

ELOCON

Erectile Dysfunction

LEVITRA (Co-promoted with GlaxoSmithKline PLC)

Specialty Care including

Anti-infectives

INTRON A, PEG-INTRON, REBETOL

Anti-inflammatories

REMICADE

Oncology

TEMODAR, CAELYX, INTRON A,

Acute Coronary Care

INTEGRILIN

Other

SUBUTEX, SUBOXONE

Cholesterol, through the Merck/ Schering-Plough Joint Venture

ZETIA, VYTORIN

Consumer Health Care, which is organized into categories as follows:

Over-the-Counter

CLARITIN, AFRIN, CORICIDIN, A+D OINTMENT, CORRECTOL, DRIXORAL, GYNE-LOTRIMIN

Foot Care

DR. SCHOLL’S, LOTRIMIN, TINACTIN

Sun Care

COPPERTONE, BAIN DE SOLEIL, SOLARCAINE

Animal Health, which is organized into categories as follows:

Livestock

BANAMINE, NUFLOR

Poultry

PARACOX, UNIVAX-PLUS

Companion Animal

HOMEAGAIN

Aquaculture

AQUAFLOR, SLICE

   

Sales by Geography Competition By Business Segments Company Profile
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KYLK's Profile

Stock Price

KYLK's Financials

KYLK's Expectations

Business Description

Fundamentals

Charts & Quotes

KYLK's News

Suppliers

KYLK's Competitors

Customers & Markets

Economic Indicators

KYLK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com